Literature DB >> 7977908

Tuberculosis: is the past once again prologue?

G W Comstock1.   

Abstract

Tuberculosis has been considered the result of hereditary susceptibility, miasmas in the environment, and contact with contagious patients. During most of the latter half of this century, tuberculosis control efforts have concentrated almost exclusively on contagion by treating patients to make them noninfectious, treating latent tuberculosis to prevent reactivation, and in some countries, vaccinating uninfected persons to protect them from the consequences of infection. With the resurgence of tuberculosis in 1985, interest in all methods of tuberculosis control has been rekindled. Much remains to be discovered and much needs to be done. If renewed efforts succeed in again forcing tuberculosis rates downward, will we have the wisdom to eliminate tuberculosis in the United States, or will we relax and bring about another resurgence?

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7977908      PMCID: PMC1615228          DOI: 10.2105/ajph.84.11.1729

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  3 in total

1.  The historical decline of tuberculosis in Europe and America: its causes and significance.

Authors:  L G Wilson
Journal:  J Hist Med Allied Sci       Date:  1990-07       Impact factor: 2.088

2.  Public Health Weekly Reports for JULY 1, 1949.

Authors: 
Journal:  Public Health Rep       Date:  1949-07-01       Impact factor: 2.792

3.  Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs.

Authors:  K Brudney; J Dobkin
Journal:  Am Rev Respir Dis       Date:  1991-10
  3 in total
  2 in total

1.  What it takes to control tuberculosis.

Authors:  C R Horsburgh
Journal:  Am J Public Health       Date:  1998-07       Impact factor: 9.308

2.  Tuberculosis control and social change.

Authors:  T R Frieden
Journal:  Am J Public Health       Date:  1994-11       Impact factor: 9.308

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.